The Valley Desk

NCT00006089 · Interventional trial

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Overall registry status Completed

Phase 2

Conditions ERBB2 Gene Amplification, Endometrial Adenocarcinoma, Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov